1. Classification of statins/dosages according to the attainable
reduction of cholesterol-low-density lipoprotein (c-LDL) level
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]

2. Use of statins in the Emilia Romagna region of Italy, in Italy and in the cohort of the present study
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]

3. Distribution of patients by choice of statin, tablet dosage and number of tablets received in the year
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]
Note: The figure on lovastatin is not shown due to the low prevalence of use of the drug (only 68 patients were prescribed lovastatin)

4. Patients’ characteristics
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]

5. Distribution of patients according to cardiovascular risk profile and coverage
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]

6. Analysis of statin coverage according to age, gender, therapeutic regimen and patient’s risk factors
Poluzzi E, et al. Eur J Clin Pharmacol 2008 [Epub ahead of print]